Actualités bibliographiques
2026
Chanzy P, Khalifé M, Morardet L, Pascal-Moussellard H, Bonaccorsi R, Marie-Hardy L.World J Surg Oncol. 2026 Aug 1;24(1):408. doi: 10.1186/s12957-026-04531-z.
Lepot D, Chabot C, Duchêne G, Mandava S, Fung M, Poujol J, Vekemans MC, Triqueneaux P, Watté N, Gheysens O, Michoux N, Lecouvet FE.Eur Radiol Exp. 2026 Jun 5;10(1):81. doi: 10.1186/s41747-026-00734-x.
The Importance of Molecular Imaging Response Criteria: Rationale and Overview.
Lopci E, Dhima A, Deroose CM, Lecouvet FE.Br J Radiol. 2026 Oct 14:tqag241. doi: 10.1093/bjr/tqag241.
Clinical trial endpoints for metastases-directed therapy in oligometastatic cancer: a review and Delphi consensus on behalf of the EORTC-ESTRO OligoCare consortium.
Widder J, Bol GM, Simek IM, Ehret F, Abdel-Aty H, Basic S, Chuter D, Daly J, Fairbrother P, Zeqa D, Aboubakar Nana F, Achard V, Corradini S, Correia D, De Ruysscher D, Dingemans AC, Faivre-Finn C, Gillessen S, Guren MG, Hendriks L, Kunz WG, Lecouvet FE, Levy A, Lievens Y, McDonald F, Meattini I, Oppong F, Oprea-Lager D, Palma D, Fredberg Persson G, Remon J, Vandemaele M, van Laarhoven HWM, Verkooijen HM, Visani L, Zilli T, Ost P, Guckenberger M.Lancet Oncol. 2026 May;27(5):e238-e247. doi: 10.1016/S1470-2045(26)00075-6.
Lecouvet FE, Taihi L, Kirchgesner T, Pasoglou V, Halut M, Tuba Sanal H, Gitto S, Martín-Noguerol T, Vasilevska-Nikodinovska V, Vanhoenacker F, Vilanova JC.Eur Radiol. 2026 Jul;36(7):5414-5428. doi: 10.1007/s00330-025-12307-4
ESUR: Opportunities for PSMA-PET/CT and whole-body MRI in advanced prostate cancer.
Woo S, Russo L, Withey SJ, Dehghanpour A, García-Figueiras R, Schoots IG, Petralia G, Lakhani A, Penzkofer T, Pecoraro M, Wu CJ, Walz J, Eiber M, Fendler WP, Gillessen S, Perez-Lopez R, Lecouvet FE, Barwick TD, Padhani AR; ESUR Prostate MRI Working Group.Eur Radiol. 2026 Apr;36(4):2794-2812. doi: 10.1007/s00330-025-12089-9. Epub 2025 Nov 5.
Shagera QA, Gheysens O, Jonard E, Seront E, Lhommel R, Lecouvet FE, Tombal B, Jamar F.Eur J Nucl Med Mol Imaging. 2026 Feb;53(3):1782-1788. doi: 10.1007/s00259-025-07589-1.
Faivre JC, Lambert A, Bruand M, Francais A, Supiot S, Thureau S, Bourbonne V, Tomaszewski F, Charra-Brunaud C, Py JF, Stefani A, Jolnerovski M, Demogeot N, Cuenin M, Renard S, Sellami S, Trampetti I, Bernier-Chastagner V, Jacques J, Agnoux E, Appavou RA, Gehin W, Martz N, Mammari N.BMC Cancer. 2026 Apr 24;26(1):720. doi: 10.1186/s12885-026-16053-8.
Gehin W, Faivre JC, Bibault JE, Thiery Y, Deon S, Desandes E, Lambert A, Baudin A, Schoumacker M, Eschwege P, Supiot S, Perennec T, Peiffert D.NPJ Digit Med. 2026 Jul 28;9(1):748. doi: 10.1038/s41746-026-03073-8
Follet H, Meysen A, Allard V, Gardegaront M, Levillain A, Roux JP, Bermond F, Poncioni S, Schenk D, Stadelmann M, Heidsieck C, Skalli W, Barrey C, Confavreux C, Pialat JB, Alkalay R, Mitton D.J Mech Behav Biomed Mater. 2026 Dec;184:107633. doi: 10.1016/j.jmbbm.2026.107633.
Confavreux CB, Bouvard B, Blank R, Hadji P, Biver E, Body JJ, Brandi ML, Campusano C, Ebeling PR, Maghraoui AE, Holzer G, Kendler D, de Villiers T, Rizzoli R, Foldes AJ.Osteoporos Int. 2026 Sep 8. doi: 10.1007/s00198-026-08178-0.
Massy E, Stacoffe N, Fauvernier M, Duruisseaux M, Grolleau E, Lamkhioued M, Pérol M, Domblides C, Roche M, Stuani A, Clézardin P, Bonnelye E, Pialat JB, Girard N, Confavreux C.J Bone Oncol. 2026 Aug 17;60:100797. doi: 10.1016/j.jbo.2026.100797.
Anzalone L, Saillard E, Gardegaront M, Fillot L, Levillain A, Pialat JB, Proriol M, Massy E, Barrey C, Grenier T, Mitton D, Confavreux CB, Follet H.J Mech Behav Biomed Mater. 2026 Jun;178:107415. doi: 10.1016/j.jmbbm.2026.107415.
Anzalone L, Follet H, Meynard A, Confavreux C, Fasinella MR, Emery E, Mitton D, Barrey CY.Neurochirurgie. 2026 Jul;72(4):101830. doi: 10.1016/j.neuchi.2026.101830.
Tetraploidy in cancer: Diagnostic and therapeutic perspectives.
Lessa A, Levergeois R, Muños-Garcia J, Mountford J, Vargas-Franco JW, Cochonneau D, Renodon-Cornière A, Heymann MF, Giurgea I, Heymann D, Lézot F.Biochem Pharmacol. 2026 Sep;251(Pt 2):118157. doi: 10.1016/j.bcp.2026.118157.
Wuts J, Ceranka J, Michoux N, Lecouvet F, Vandemeulebroucke J.
J Bone Oncol. 2026 Jan 28;57:100745.
https://doi: 10.1016/j.jbo.2026.100745.
Lecouvet FE, Taihi L, Kirchgesner T, Pasoglou V, Halut M, Tuba Sanal H, Gitto S, Martín-Noguerol T, Vasilevska-Nikodinovska V, Vanhoenacker F, Vilanova JC.
Eur Radiol. 2026 Feb 9.
https://doi: 10.1007/s00330-025-12307-4.
ESUR: Opportunities for PSMA-PET/CT and whole-body MRI in advanced prostate cancer.
Woo S, Russo L, Withey SJ, Dehghanpour A, García-Figueiras R, Schoots IG, Petralia G, Lakhani A, Penzkofer T, Pecoraro M, Wu CJ, Walz J, Eiber M, Fendler WP, Gillessen S, Perez-Lopez R, Lecouvet FE, Barwick TD, Padhani AR; ESUR Prostate MRI Working Group.
Eur Radiol. 2025 Nov 5.
https://doi: 10.1007/s00330-025-12089-9.
A Randomized Phase 1 Study Comparing the PK, PD, Safety, and Immunogenicity of Proposed Biosimilar RGB-14-X and Denosumab in Healthy Adult Males.
Biver E, Body JJ, Sachdeva A, Študentová H, Nagy Z, Kun A, Horvát-Karajz K, Kiefer J, Pap T, Jókai E, Vasas FB, Seefried L.
Clin Transl Sci. 2026 Feb;19(2):e70468.
https://doi: 10.1111/cts.70468.
Non-metastatic breast cancer patients discontinuing aromatase inhibitor on denosumab: what next?
Marcucci G, Biver E, Body JJ, Campusano C, Cannata-Andía J, Confavreux C, de Villiers TJ, Ebeling PR, Hadji P, Kendler D, El Maghraoui A, Napoli N, Veronesi P, Rizzoli R, Brandi ML.
Osteoporos Int. 2026 Jan 12.
https://doi: 10.1007/s00198-025-07798-2.
Confavreux CB, Bouvard B, Girard N, Bosco-Levy P, Marchal C, Nolin M, Lehmann E, Desameric G, Belhassen M.
J Bone Oncol. 2026 Jan 4;56:100738.
https://doi: 10.1016/j.jbo.2025.100738.
Green Perspectives in Radiation Oncology.
Le Guevelou J, Ali D, Supiot S.
Eur Urol Oncol. 2026 Feb;9(1):164-167.
https://doi: 10.1016/j.euo.2025.05.020.
Atg5/Autophagy inactivation in mouse bone microenvironment promotes tumor development.
Trojani MC, Nollet M, Camuzard O, Santucci-Darmanin S, Breuil V, Burel-Vandenbos F, Fradet L, Le Gall M, Salnot V, Heymann D, Carle GF, Pierrefite-Carle V.Autophagy. 2026 Feb 12:1-18.
https://doi: 10.1080/15548627.2026.2624756.
Bassi G, Saqawa M, Apolloni L, Díaz-Prado S, Ollivier E, Levergeois R, Sandri M, Campodoni E, Cochonneau D, Panseri S, Heymann D, Montesi M.
Biomed Pharmacother. 2026 Feb;195:118956.
https://doi: 10.1016/j.biopha.2025.118956.
[Three-dimensional cell cultures: Applications to cancer biology].
Jubelin C, Golias M, Cochonneau D, Muñoz-Garcia J, Heymann D.
Bull Cancer. 2026 Jan;113(1):26-47.
https://doi: 10.1016/j.bulcan.2025.09.004.
2025
Tackling myeloma bone disease: From pathophysiology to cutting-edge therapies.
Roux S, Debiais F, Vieillard MH.Blood Rev. 2025 Nov;74:101305. doi: 10.1016/j.blre.2025.101305.
Massy E, Confavreux CB, Point M, Bonnelye E, Clézardin P
Neoplasia. 2025 Nov;69:101224.
https://doi: 10.1016/j.neo.2025.101224.
Rogé M, Bowden P, Conway P, Franzese C, Scorsetti M, Seront E, Blanchard P, Terlizzi M, Khalifa J, Pasquier C, Shick U, Siva S, Paul J, Supiot S.
Clin Transl Radiat Oncol. 2025 Mar 10;52:100944.
https://doi: 10.1016/j.ctro.2025.100944
Treatment Response Evaluation in Prostate Cancer Using PSMA PET/CT.
Gafita A, Schroeder JA, Ceci F, Oldan JD, Khandani AH, Lecouvet FE, Solnes LB, Rowe SP.
J Nucl Med. 2025 Jul 1;66(7):995-1004.
https://doi: 10.2967/jnumed.
Tombal B, Choudhury A, Saad F, Gallardo E, Soares A, Loriot Y, McDermott R, Rodriguez-Vida A, Isaacsson Velho P, Nolè F, Cruz F, Roumeguere T, Daugaard G, Yamamura R, Bompas E, Maroto P, Gomez Veiga F, Skoneczna I, Martins da Trindade K, Mavignier Carcano F, Lecouvet F, Coens C, Poncet C, Fournier B, Gillessen S.
Ann Oncol. 2025 Sep;36(9):1058-1067.
https://doi: 10.1016/j.annonc.2025.05.011.
Nieuwenhove SV, Lhommel R, Pasoglou V, Damme JV, Michoux N, Triqueneaux P, Tombal B, Lecouvet FE.
Eur J Radiol. 2025 May;186:112033.
https://doi: 10.1016/j.ejrad.2025.112033.
Gillessen S, Tombal B, Turco F, Choudhury A, Rodriguez-Vida A, Gallardo E, Velho PI, Nolè F, Cruz F, Loriot Y, McDermott R, Roumeguere T, Daugaard G, Yamamura R, Bompas E, Maroto P, Polo MH, da Trindade KM, Preto DD, Skoneczna I, Lecouvet F, Coens C, Fournier B, Saad F.
Eur Urol. 2025 Mar;87(3):285-288.
https://doi: 10.1016/j.eururo.2024.11.027.
French recommendations from the AFU Cancer Committee for prostate cancer: 2025 summary of changes.
Ploussard G, Baboudjian M, Barret E, Brureau L, Dariane C, Fiard G, Fromont G, Mathieu R, Olivier J, Neuzillet Y, Rozet F, Peyrottes A, Renard-Penna R, Sargos P, Supiot S, Turpin L, Roubaud G, Rouprêt M.
Fr J Urol. 2025 Dec;35(12):103010.
https://doi: 10.1016/j.fjurol.2025.103010.
Gobert A, Timsit MO, Blanchard P, Artignan X, Crehange G, Ingels A, Chebbah M, Le Clanche S, Laguerre B, Rigaud J, Rozet F, Serrate C, Supiot S, Mongiat-Artus P, Mathieu R.
Fr J Urol. 2025 Dec;35(12):103000.
https://doi: 10.1016/j.fjurol.2025
Rousseau A, Karimi M, Michiels S, Roubaud G, Maldonado X, Supiot S, McDermott R, Flechon A, Tombal B, Ronchin P, Berthold D, Berdah JF, Kacso G, Gravis G, Calabro F, Tartas S, Muracciole X, Ribault H, Fizazi K, Foulon S.
Eur J Cancer. 2025 Nov 17;230:116024.
https://doi: 10.1016/j.ejca.2025.116024.
Value of Whole-body Magnetic Resonance Imaging Using the MET-RADS-P Criteria for Assessing the Response to Intensified Androgen Deprivation Therapy in Metastatic Hormone-naïve and Castration-resistant Prostate Cancer.
Van Damme J, Tombal B, Michoux N, Van Nieuwenhove S, Pasoglou V, Triqueneaux P, Padhani AR, Lecouvet FE.
Eur Urol Oncol. 2025 Jun;8(3):689-699.
https://doi: 10.1016/j.euo.2024.10.009.
Epidemiology of bone metastasis in France between 2009 and 2018.
Marchal C, Belhassen M, Désaméricq G, Lehmann E, Walter M, Bosco-Levy P, Girard N, Bouvard B, Confavreux CB.
JBMR Plus. 2025 May 6;9(8):ziaf081.
https://doi: 10.1093/jbmrpl/ziaf081.
Bone Effects of Anti-Cancer Treatments in 2024.
Teissonnière M, Point M, Biver E, Hadji P, Bonnelye E, Ebeling PR, Kendler D, de Villiers T, Holzer G, Body JJ, Fuleihan GEH, Brandi ML, Rizzoli R, Confavreux CB.Calcif Tissue Int. 2025 Mar 27;116(1):54.
https://doi: 10.1007/s00223-025-01362-0.
Graham R, Morland D, Cade S, Imbert L, Panagiotidis E, Kurth J, Paycha F, Van den Wyngaert T.Eur J Nucl Med Mol Imaging. 2025 Feb;52(3):1200-1209.
https://doi: 10.1007/s00259-024-06906-4.
Oligometastatic head and neck cancer: Navigating patient trajectories and broader implications.
Thariat J, Lehyanti J, Boisselier P, Modesto A, Thureau S, Pointreau Y, Sun XS.Cancer Radiother. 2025 Sep-Oct;29(5-6):104675.
https://doi: 10.1016/j.canrad.2025.104675.
Radiotherapy for lung metastases.
Levy A, Tonneau M, Darréon J, Khalifa J, Antoni D, Blais E, Le Péchoux C, Lerouge D, Lucia F, Marguerit A, Martin É, Pichon B, Pourel N, Riet FG, Giraud P, Thureau S.Cancer Radiother. 2025 Nov-Dec;29(7-8):104760.
https://doi: 10.1016/j.canrad.2025.104760
Radiotherapy of bone metastases: 2025 update.
Martz N, Faivre JC, Beldjoudi G, Arnaud A, Chamois J, Supiot S, Rogé M, Thureau S.Cancer Radiother. 2025 Nov-Dec;29(7-8):104769.
https://doi: 10.1016/j.canrad.2025.104769.
Zhou Y, Escande A, Beddok A, Chargari C, Sunyach MP, Ayadi M, Khalifa J, Antoni D, Cao K, Pasquier D, Hannoun-Lévi JM, Langé M, Faivre JC, Thureau S, Supiot S.Cancer Radiother. 2025 Nov-Dec;29(7-8):104780.
https://doi: 10.1016/j.canrad.2025.104780.
Tackling myeloma bone disease: From pathophysiology to cutting-edge therapies.
Roux S, Debiais F, Vieillard MH.Blood Rev. 2025 Nov;74:101305.
https://doi: 10.1016/j.blre.2025.101305.
Golfier C, Visy A, Gueiderikh A, Marcel J, Escande A, Scala-Bertola J, Metzger M, Lambert A, Faivre JC. Cancer Metastasis Rev. 2025 Nov 14;44(4):83.
https://doi: 10.1007/s10555-025-10296-w
Guidelines about radiotherapy and oncologic systemic treatments: Stop or continue?
Buchalet C, Golfier C, Faivre JC, Azria D, Kirova Y, Lapierre A, Latorzeff I, Mirjolet C, Hennequin C, Leroy T, Marcel J.Cancer Radiother. 2025 Nov-Dec;29(7-8):104757.
https://doi: 10.1016/j.canrad.2025.104757.
Radiation therapist, a key player in radiotherapy research.
Boisbouvier S, Hulot-Geffroy C, Boucaud A, Tachin-Bourgeon C, Salesses F, Faivre JC.Cancer Radiother. 2025 Sep-Oct;29(5-6):104686.
https://doi: 10.1016/j.canrad.2025.104686.
Cravéreau O, Bourbonne V, Vaugier L, Lucia F, Le Tinier F, Cadranel J, Duchemann B, Habert P, Martz N, Gehin W, Bruand M, Stefani A, Marcel J, Trampetti I, Clément-Duchêne C, Lerouge D, Laville A, Cao K, Pourel N, Zaccariotto A, Bellière-Calendry A, Thillays F, Tanguy R, Antoni D, Girard N, Martin É, Godbert B, Nakad A, Treffel G, Massin M, Charzat V, Thureau S, Lapierre A, Faivre JC. Cancer Radiother. 2025 Sep-Oct;29(5-6):104687.
https://doi: 10.1016/j.canrad.2025.104687.
177 Lu-PSMA-617 Radioligand Therapy in Patient With Prostate Cancer Sciatic Nerve Metastasis.
Tonnelet D, Edet-Sanson A, Augusto L, Cabourg M, Thureau S.
Clin Nucl Med. 2024 Dec 1;49(12):e668-e669.
https://doi: 10.1097/RLU.0000000000005503.
Mesny E, Martz N, Stacoffe N, Clarençon F, Louis M, Mansouri N, Sirveaux F, Thureau S, Faivre JC.
Cancer Metastasis Rev. 2025 Apr 12;44(2):45.
https://doi: 10.1007/s10555-025-10262-6.
Gueiderikh A, Faivre JC, Golfier C, Escande A, Thureau S.
Cancer Metastasis Rev. 2025 Jan 29;44(1):28.
https://doi: 10.1007/s10555-024-10236-0.
Bone, a double victim in metastatic catecholamine secreting tumors.
Jannin A, Vieillard MH, Lion G, Chevalier B, Beron A, Vantyghem MC, Cardot-Bauters C, Chapurlat R, Do Cao C, Espiard S.
Ann Endocrinol (Paris). 2025 Jul;86(4):101792.
https://doi: 10.1016/j.ando.2025.101792.
Is surgery without curettage effective for periacetabular Metastasis? Insights from a survival study of 93 patients.
Amouyel T, Vieillard MH, Duhamel A, Maynou C, Duterque-Coquillaud M, Dumont C.
J Bone Oncol. 2024 Oct 10;49:100643.
https://doi: 10.1016/j.jbo.2024.100643.
Séguier D, Parent P, Duterque-Coquillaud M, Labreuche J, Fromont-Hankard G, Dariane C, Penel N, Villers A, Turpin A, Olivier J.
Eur Urol Oncol. 2025 Apr;8(2):581-590.
https://doi: 10.1016/j.euo.2024.12.014.
Advancing cancer research through 3D cell culture models.
Panez-Toro I, Mountford J, Muñoz-Garcia J, Heymann D.
EXCLI J. 2025 Aug 28;24:1061-1099.
https://doi: 10.17179/excli2025-8563
Circulating tumour cells for the prediction of the response to radiation therapy in prostate cancer.
Landry C, Klusa D, Cochonneau D, Supiot S, Heymann D.
Br J Radiol. 2025 Nov 1;98(1175):1899-1911.
https://doi: 10.1093/bjr/tqaf224.
Pre-clinical Murine Models of Bone Sarcomas.
Muñoz-Garcia J, Vargas-Franco JW, Grigoriadis AE, Lézot F, Heymann D.
Methods Mol Biol. 2025;2885:383-398.
https://doi: 10.1007/978-1-0716-4306-8_20.
Targeting metastasis in paediatric bone sarcomas.
Bull EC, Singh A, Harden AM, Soanes K, Habash H, Toracchio L, Carrabotta M, Schreck C, Shah KM, Riestra PV, Chantoiseau M, Da Costa MEM, Moquin-Beaudry G, Pantziarka P, Essiet EA, Gerrand C, Gartland A, Bojmar L, Fahlgren A, Marchais A, Papakonstantinou E, Tomazou EM, Surdez D, Heymann D, Cidre-Aranaz F, Fromigue O, Sexton DW, Herold N, Grünewald TGP, Scotlandi K, Nathrath M, Green D.
Mol Cancer. 2025 May 29;24(1):153.
https://doi: 10.1186/s12943-025-02365-z.
De Cock L, Palubeckaitė I, Bersani F, Faehling T, Pasquali S, Umbaugh S, Meister MT, Danks MR, Manasterski P, Miallot R, Krumbholz M, Roohani S, Heymann D, Cidre-Aranaz F, Wozniak A, Schöffski P, Bovée JVMG, Merlini A, Venneker S.
Neoplasia. 2025 Jul;65:101171.
https://doi: 10.1016/j.neo.2025.101171.
Yadav P, Rajendrasozhan S, Lajimi RH, Patel RR, Heymann D, Prasad NR.
Front Oncol. 2025 Apr 7;15:1494723.
https://doi: 10.3389/fonc.2025.1494723.
Interleukin-34 orchestrates bone formation through its binding to bone morphogenic proteins.
Muñoz-Garcia J, Vargas-Franco JW, Schiavone K, Keatinge MT, Young R, Amiaud J, Fradet L, Jégou JF, Yagita H, Blin-Wakkach C, Wakkach A, Cochonneau D, Ollivier E, Pugière M, Henriquet C, Legendre M, Giurgea I, Amselem S, Heymann MF, Télétchéa S, Lézot F, Heymann D.
Theranostics. 2025 Feb 11;15(7):3185-3202.
https://doi: 10.7150/thno.107340.
2024
Ignatiadis M, Poulakaki F, Spanic T, Brain E, Lacombe D, Sonke GS, Vincent-Salomon A, Van Duijnhoven F, Meattini I, Kaidar-Person O, Aftimos P, Lecouvet F, Cardoso F, Retèl VP, Cameron D.
Journal: Eur J Cancer
Année: aug 2024
Volume: 207
Devis M, Lecouvet F, Lejeune T, Stoquart G.
Journal: Eur J Phys Rehabil Med
Année: jul 2024
Cordova LA, González-Quintanilla D, Heymann D.
Journal: Osteoporos Int.
Année: jun 2024
Childs A, Gerrand C, Brennan B, Young R, Rankin KS, Parry M, Stevenson J, Flanagan AM, Taylor RM, Fern L, Heymann D, Vance F, Sherriff J, Singh S, Begum R, Forsyth SL, Reczko K, Sparksman K, Wilson W, Strauss SJ
Journal: Cancers (Basel)
Année: jun 2024
Volume: 28, Issue 1
Pages: 111-118
Scott AM, Zeglis BM, Lapi SE, Scott PJH, Windhorst AD, Abdel-Wahab M, Giammarile F, Piaez D, Jalilian A, Knoll P, Korde A, Vichare S, Ayati N, Lee ST, Lyashchenko SK, Zhang J, Urbain JL, Lewis JS.
Journal: Lancet Oncol.
Année: jun 2024
Volume: 25, Issue 6
Pages: e250-e259
Lapi SE, Scott PJH, Scott AM, Windhorst AD, Zeglis BM, Abdel-Wahab M, Baum RP, Buatti JM, Giammarile F, Kiess AP, Jalilian A, Knoll P, Korde A, Kunikowska J, Lee ST, Paez D, Urbain JL, Zhang J, Lewis JS.
Journal: Lancet Oncol.
Année: jun 2024
Volume: 25, Issue 6
Pages: e236-e249
Giammarile F, Paez D, Zimmermann R, Cutler CS, Jalilian A, Korde A, Knoll P, Ayati N, Lewis JS, Lapi SE, Delgado Bolton RC, Kunikowska J, Estrada Lobato E, Urbain JL, Holmberg O, Abdel-Wahab M, Scott AM.
Journal: Lancet Oncol.
Année: jun 2024
Volume: 25, Issue 6
Pages: e260-e269
Cardoso F, Paluch-Shimon S, Schumacher-Wulf E, Matos L, Gelmon K, Aapro MS, Bajpai J, Barrios CH, Bergh J, Bergsten-Nordström E, Biganzoli L, Cardoso MJ, Carey LA, Mac Gregor MC, Chidebe R, Cortés J, Curigliano G, Dent RA, El Saghir NS, Eniu A, Fallowfield L, Francis PA, Franco Millan SX, Gilchrist J, Gligorov J, Gradishar WJ, Haidinger R, Harbeck N, Hu X, Kaur R, Kiely B, Kim SB, Koppikar S, Kuper-Hommel MJJ, Lecouvet FE, Mason G, Mertz SA, Mueller V, Myerson C, Neciosup S, Offersen BV, Ohno S, Pagani O, Partridge AH, Penault-Llorca F, Prat A, Rugo HS, Senkus E, Sledge GW, Swain SM, Thomssen C, Vorobiof DA, Vuylsteke P, Wiseman T, Xu B, Costa A, Norton L, Winer EP
Journal: The Breast
Année: aug 2024
Volume: 76
Ah-Thiane L, Campion L, Allouache N, Meyer E, Pommier P, Mesgouez-Nebout N, Serre AA, Créhange G, Guimas V, Rio E, Sargos P, Ladoire S, Mahier Ait Oukhatar C, Supiot S.
Journal: Eur Urol Oncol.
Année: may 2024
Szulc P, Dufour AB, Hannan MT, Kiel DP, Chapurlat R, Sornay-Rendu E, Merle B, Boyd SK, Whittier DE, Hanley DA, Goltzman D, Wong AKO, Lespessailles E, Khosla S, Ferrari S, Biver E, Bouxsein ML, Samelson EJ
Journal: J Bone Miner Res.
Année: may 2024
Volume: 39, Issue 5
Pages: 561-570
Rey V, Tornín J, Alba-Linares JJ, Robledo C, Murillo D, Rodríguez A, Gallego B, Huergo C, Viera C, Braña A, Astudillo A, Heymann D, Szuhai K, Bovée JVMG, Fernández AF, Fraga MF, Alonso J, Rodríguez R.
Journal: EBioMedicine
Année: apr 2024
Volume: 102
Jeka S, Dokoupilová E, Kivitz A, Żuchowski P, Vogg B, Krivtsova N, Sekhar S, Banerjee S, Schwebig A, Poetzl J, Body JJ, Eastell R
Journal: J Bone Miner Res.
Année: apr 2024
Volume: 39 Issue 3
Pages: 202-210
Vaugier L, Morvan C, Pasquier D, Buthaud X, Magné N, Beckendorf V, Sargos P, Crehange G, Pommier P, Loos G, Hasbini A, Latorzeff I, Silva M, Paul J, Blanc-Lapierre A, Supiot S.
Journal: Eur Urol.
Année: mar 2024
Jubelin C, Muñoz-Garcia J, Ollivier E, Cochonneau D, Vallette F, Heymann MF, Oliver L, Heymann D.
Journal: Biochim Biophys Acta Mol Cell Res.
Année: mar 2024
Volume: 1871, Issue 3
Pascual TNB, Paez D, Iagaru A, Gnanasegaran G, Lee ST, Sathekge M, Buatti JM, Giammarile F, Al-Ibraheem A, Pardo MA, Baum RP, De Bari B, Ben-Haim S, Blay JY, Brink A, Estrada-Lobato E, Fanti S, Golubic AT, Hatazawa J, Israel O, Kiess A, Knoll P, Louw L, Mariani G, Mirzaei S, Orellana P, Prior JO, Urbain JL, Vichare S, Vinjamuri S, Virgolini I, Scott AM.
Journal: Eur J Nucl Med Mol Imaging
Année: mar 2024
Volume: 51
Pages: 2320-2331
Naessens C, Chamois J, Supiot S, Faivre JC, Arnaud A, Thureau S.
Journal: Cancer/Radiothérapie
Année: feb 2024
Volume: 28, Issue 1
Pages: 111-118
Tonneau M, Nebbache R, Larnaudie A, Thureau S, Pointreau Y, Blanchard P, Thariat J.
Journal: Cancer/Radiothérapie
Année: feb 2024
Volume: 28, Issue 1
Pages: 83-92
Géraud A, Combarel D, Funck-Brentano C, Beaulieu Q, Zahr N, Broutin S, Spano JP, Massard C, Besse B, Gougis P.
Journal: Clin Pharmacol Ther.
Année: feb 2024
Ollivier L, Debbi K, To NH, Cailleteau A, Supiot S, Mervoyer A, Guimas V, Belkacémi Y.
Journal: Cancer/Radiothérapie
Année: feb 2024
Volume: 28, Issue 1
Pages: 119-130
Miszczyk M, Rajwa P, Yanagisawa T, Nowicka Z, Shim SR, Laukhtina E, Kawada T, von Deimling M, Pradere B, Rivas JG, Gandaglia G, van den Bergh RCN, Goldner G, Supiot S, Zilli T, Trinh QD, Nguyen PL, Briganti A, Ost P, Ploussard G, Shariat SF
Journal: Eur Urol.
Année: feb 2024
Volume: 85, Issue 2
Pages: 125-138
Giammarile F, Knoll P, Kunikowska J, Paez D, Estrada Lobato E, Mikhail-Lette M, Wahl R, Holmberg O, Abdel-Wahab M, Scott AM, Delgado Bolton RC
Journal: Eur J Nucl Med Mol Imaging
Année: feb 2024
Volume: 51
Pages: 1498-1505
Huguet F, Tlemsani C, Pierga JY, Curtit E, Deluche E, Domblides C, Guimbaud R, Laprie A, Marchal F, Massard C, Spano JP
Journal: Bulletin du Cancer
Année: feb 2024
Volume: 111, Issue 2
Pages: 133-141
Di Mauro P, Croset M, Bouazza L, Clézardin P, Reynaud C.
Journal: J Bone Oncol.
Année: feb 2024
Volume: 44
Almeida LS, Etchebehere ECSC, García Megías I, Calapaquí Terán AK, Hadaschik B, Colletti PM, Herrmann K, Giammarile F, Delgado Bolton RC
Journal: Clin Nucl Med
Année: jan 2024
Volume: 49, Issue 1
Pages: 44-55